Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2639-2646

  Berois, Nora ^a,b   Varangot, Mario ^c   Osinaga, Eduardo ^a   Babino, Alvaro ^a   Caignault, Laurent ^b   Musé, Ignacio ^d   Roseto, Alberto ^b  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^c HOSPITAL DE CLÍNICAS   (Uruguay)

^d NONE

Author keywords

Breast cancer; Cancer associated glycoproteins; Cytokeratin 19; Immunobeads; Micrometastasis; RT PCR

Indexed keywords

CYTOKERATIN 19 FRAGMENT; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL SEPARATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; KERATINS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0030758565     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Henderson I: Adjuvant systemic therapy of early breast cancer. In: Breast diseases, Edited by Harris J; Hellman S; Henderson, I. and Kinne, D. Eds. Lippincott Company, Philadelphia. 1991, pp 427-486.
2. Elledge R, McGuire W and Osborne K: Prognostic factors in breast cancer. Semin Oncol 19: 244-253, 1992.
3. Papac R: Bone marrow metastases. A review. Cancer 74: 2403-2413, 1994.
4. Schlimock G, Funke I, Holzmann B, Gottlinger H, Schmidt G, Hauser H, Swierkot S, Warnecke H, Schneider B, Koprowski H and Riethmuller G: Micrometastatic cancer cells in bone marrow: in vitro detection with anticytokeratin and in vivo labelling with anti 17-lA-monoclonal antibodies. Proc. Natl. Acad. Sci. (USA) 84: 8672-8676, 1987.
5. Cote R, Rosen P, Lesser M, Old L and Osborne M: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756, 1991.
6. Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne D, Old L and Osborne M: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12: 333-340, 1988.
7. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles T and Coombes, RC: Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093-1096, 1987.
8. Mansi JL, Easton D, Berger U, Gazet J, Ford H, Dearnaley D and Coombes R: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27: 1552-1555, 1991.
9. Diel IJ, Kaufmann M, Goerner R, Costa S, Kaul S and Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J. Clin. Oncol. 10:1534-1539, 1992.
10. Riethmuller G and Johnson J: Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr. Opin. Immunol. 4:647-655, 1992.
11. Dearnaley D, Sloane J, Ormerod M, Steele K, Coombes R, Clink H, Powles T, Ford H, Gazet J and Neville A: Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br. J. Cancer 44: 85-90, 1981.
12. Delsol G, Gatter K, Stein H, Erber W, Pulfod K, Zinne K and Mason D: Human lymphoid cells express epithelial membrane antigen: implications for diagnosis of human neoplasms. Lancet 2: 1124-1128, 1984.
13. Heydermann, E. and McCartney, J. Epithelial membrane antigen and lymphoid cells. Lancet 1: 109, 1985.
14. Diel I, Kaufmann M, Costa S and Bastert G: Monoclonal antibodies to detect breast cancer cells in bone marrow. In: Important Advances in Oncology 1994, Edited by De Vita V, Hellman S and Rosenberg, S. Lippincott Company, Philadelphia, 1994, pp: 143-164.
15. Nagle R: Intermediate filaments: a review of basic biology. Am. J. Surg. Pathol. 12 (Suppl. 1): 416, 1988
16. Lindemann F, Schlimok G, Dirschedl P, Witte J and Riethmuller G: Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689, 1992.
17. Harbeck, N, Untch M, Pache L and Eiermann W: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy - Results of a 3 year median follow-up. Br J Cancer 69: 566-571, 1994.
18. Johnson P, Burchill S and Selby P: The molecular detection of circulating tumour cells, Br J Cancer 72: 268-276, 1995.
19. Pancino G, Le Doussal V, Mortada M, Berthon P, Osinaga E, Calvo F and Roseto A: Characterization and distribution in normal and tumoral human tissues of breast-cancer associated antigen defined by monoclonal antibody 7B10. Cancer Res 49: 7078-7085, 1989.
20. Pancino G, Charpin C, Osinaga E. Betaille B, Le Roy M, Calvo F and Roseto A: Characterization of breast cancer associated glycoprotein defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D. Cancer Res 50: 7333-7342, 1990.
21. Mortada M, Pancino G, Charpin C, Schlageter M, Calvo F and Roseto A: A novel monoclonal antibody (ED8) detects a circulating antigen in breast cancer patient sera. C R Acad Sci (Paris) 311: 63-68, 1990
22. Pancino G, Osinaga E, Charpin C, Mistro D, Barque J Ph and Roseto A: Purification and characterization of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4. Br J Cancer 63: 390-398, 1991.
23. Miglierina R, Aubree B, Pancino G, Calvo F and Roseto A: Detection of rare metastatic breast cancer cells in the bone marrow by flow cytometry using monoclonal antibody 7B 10 in an experimental model. J. Tumor Marker Oncol 4: 45-53, 1989.
24. Pancino G, Osinaga E, Vorauher W, Kakouche A, Mistro D, Charpin C, and Roseto A: Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method. Hybridoma 9: 389-395, 1990.
25. Keydar I, Chen L, Karby S, Weiss F, Delarea J, Rendu M, Chaitek S and Brenner H: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659-670, 1979.
26. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
27. Datta Y, Adams P, Drobyski W, Ethier S, Terry V and Roth M: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482, 1994.
28. Ellis G, Ferguson M, Yamanaka E, Livingston RB and Gown AM: Monoclonal antibodies for detection occult carcinoma cells in bone marrow of breast cancer patients. Cancer 63: 2509-2514, 1989,
29. Ugelstad J, Mfutakamba HR, Mork PC, Ellingsen T, Berge A, Schmid R, Holm L, Jorgedal A, Hansen FK and Nustad K: Preparation and application of monodisperse polymer particles. J Polymer Sci 72: 225-240, 1985.
30. Osinaga E, Pancino G, Porchet N, Mistro D, Aubert JP and Roseto A: Analysis of the carcinoma-associated epitope defined by monoclonal antibody 83D4. J Tumor Marker Oncol 7: 13-24, 1992.
31. Hakomori S: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257-331, 1989.
32. Charpin C, Pancino G, Osinaga E, Bonnier P, Lavaut M, Allasia C and Roseto A: Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution, and microcytophotometric analysis of immunoprecipitates on tissue sections. Anticancer Research 12: 209-224, 1992.
33. Osinaga E, Pancino G, Porchet N, Berois N, De Cremoux P, Mistro D, Aubert JP, Calvo F and Roseto A: Analysis of an heterogeneous group of breast carcinoma associated glycoproteins bearing Tndeterminant. Breast Cancer Res Treat 32: 139-152, 1994.
34. Beuzelin-Yvraut M, Bourguignat A, Phillips E, Roseto A and Osinaga E: Immunocytological analysis of the Tn-associated antigen (83D4) in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein. J Clin Pathol 48: 433-437, 1995.
35. Traweek S, Liu J and Battifora H: Keratin expression in nonepithelial tissues. Am J Pathol 142: 1111-1118, 1993.
36. Burchill A, Bradbury M, Pittman K, Southgate J, Smith B and Selby P: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71: 278-281, 1995.
37. Myklebust A, Godal A, Juell S, Pharo A and Fodstad O: Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. Cancer Res 54: 209-214, 1994.
38. Pantel K, Dickmanns A, Zippelius A, Klein C, Shi J, Hoetchtlen-Vollmar W, Schlimok G, Weckermann D, Oberneder R, Fanning E and Riethmuller G: Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J Natl Cancer Inst 87: 1162-1168, 1995.
39. Maas R, Burning P, Breedijk A, Top B and Peterse H: Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates. Lab Invest 72: 760-764, 1995.